Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

The news is by your side.

- Advertisement -

DR. Congo To Introduce Second Ebola Vaccine

Authorities in the Democratic Republic of Congo are planning to introduce a second Ebola vaccine to help control an outbreak that has killed more than 2,100 people.

Recall that , former Health Minister Oly Ilunga had opposed its usage,saying it had not been proved effective.

But DR Congo health officials said the vaccine, developed by Johnson & Johnson, is safer and good for consumption .

- Advertisement -

- Advertisement -

This outbreak, in the east of DR Congo, is the second largest on record.

- Advertisement -

The largest was the epidemic that ravaged parts of West Africa from 2014 to 2016, killing more than 11,000 people.

ALSO READ  BREAKING: Tambuwal Tests Positive To COVID19

The Johnson & Johnson vaccine will complement the vaccine manufactured by Merck which has been administered to 225,000 people in the past year, according to a government statement.

But DR Congo’s Ebola response team have not yet said when it will be introduced.

Addressing concerns over safety, the team said, in a statement quoted by Reuters, that “it is a vaccine that other countries already use. Why can’t we use it… to protect our population?”

Leading health experts have said that the second vaccine is safe and could be an important tool in holding back the spread of the virus.

ALSO READ  NARD STRIKE: Doctors, FG Resolve To Address Pressing Issues

Comments are closed.